Skip to main content

Table 2 Clinical characteristics of CD patients in remission or active phase

From: The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn’s disease

 

Remission

Active

P value

Number of patients

9

5

 

Gender

   

 Male

3

2

0.969

 Female

6

3

Mean age (±SD), yr

28.8 ± 16.8

24.0 ± 8.7

0.898

BMI (±SD), kg/m2

18.6 ± 3.1

20.2 ± 6.3

0.898

CDAI

   

  ≥ 150

5

4

0.658

  < 150

4

1

Disease location

   

 Ileal type

3

0

0.167

 Ileocolonic type

6

4

 Colonic type

0

1

Induction therapy a

   

 5-ASA

6

3

 

 Steroid

1

0

 

 Azathioprine

2

0

 

 Infliximab

8

5

 

 Adalimumab

1

0

 

 GMA/LCAP

0

0

 

AIM (μg/ml)

   

 Before treatment

   

  Average (±SD)

3.8 ± 3.7

3.3 ± 2.1

0.797

 After treatment

   

  Average (±SD)

4.4 ± 5.3

3.1 ± 2.7

0.699

  1. asome treatments overlapped